Related references
Note: Only part of the references are listed.Immunoablation and autologous hematopoietic stem cell transplantation in the treatment of new-onset type 1 diabetes mellitus: long-term observations
E. Snarski et al.
BONE MARROW TRANSPLANTATION (2016)
Mobilization without immune depletion fails to restore immunological tolerance or preserve beta cell function in recent onset type 1 diabetes
M. J. Haller et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2016)
Antithymocyte globulin therapy for patients with recent-onset type 1 diabetes: 2 year results of a randomised trial
Stephen E. Gitelman et al.
DIABETOLOGIA (2016)
Type 1 diabetes vaccine candidates promote human Foxp3+Treg induction in humanized mice
Isabelle Serr et al.
NATURE COMMUNICATIONS (2016)
Molecular Interactions Governing Autoantigen Presentation in Type 1 Diabetes
Maki Nakayama et al.
CURRENT DIABETES REPORTS (2015)
Selective IL-2 Responsiveness of Regulatory T Cells Through Multiple Intrinsic Mechanisms Supports the Use of Low-Dose IL-2 Therapy in Type 1 Diabetes
Aixin Yu et al.
DIABETES (2015)
Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association
Richard A. Insel et al.
DIABETES CARE (2015)
Predictors of Progression From the Appearance of Islet Autoantibodies to Early Childhood Diabetes: The Environmental Determinants of Diabetes in the Young (TEDDY)
Andrea K. Steck et al.
DIABETES CARE (2015)
Use of Dried Capillary Blood Sampling for Islet Autoantibody Screening in Relatives: A Feasibility Study
Polly J. Bingley et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2015)
The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study
Jeffrey P. Krischer et al.
DIABETOLOGIA (2015)
Effects of High-Dose Oral Insulin on Immune Responses in Children at High Risk for Type 1 Diabetes The Pre-POINT Randomized Clinical Trial
Ezio Bonifacio et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients
Mark R. Rigby et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Additive and interaction effects at three amino acid positions in HLA-DQ and HLA-DR molecules drive type 1 diabetes risk
Xinli Hu et al.
NATURE GENETICS (2015)
Regulatory vs. inflammatory cytokine T-cell responses to mutated insulin peptides in healthy and type 1 diabetic subjects
Maki Nakayama et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Type 1 diabetes immunotherapy using polyclonal regulatory T cells
Jeffrey A. Bluestone et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Protocol of the adaptive study of IL-2 dose frequency on regulatory T cells in type 1 diabetes (DILfrequency): a mechanistic, non-randomised, repeat dose, open-label, response-adaptive study
Lucy A. Truman et al.
BMJ OPEN (2015)
Anti-thymocyte globulin/G-CSF treatment preserves β cell function in patients with established type 1 diabetes
Michael J. Haller et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Effect of docosahexaenoic acid supplementation on inflammatory cytokine levels in infants at high genetic risk for type 1 diabetes
H. Peter Chase et al.
PEDIATRIC DIABETES (2015)
B-Lymphocyte Depletion With Rituximab and β-Cell Function: Two-Year Results
Mark D. Pescovitz et al.
DIABETES CARE (2014)
The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Overview
David M. Nathan
DIABETES CARE (2014)
Costimulation Modulation With Abatacept in Patients With Recent-Onset Type 1 Diabetes: Follow-up 1 Year After Cessation of Treatment
Tihamer Orban et al.
DIABETES CARE (2014)
Treatment of Recent- Onset Type 1 Diabetic Patients With DiaPep277: Results of a Double- Blind, PlaceboControlled, Randomized Phase 3 Trial
Itamar Raz et al.
DIABETES CARE (2014)
Hydrolyzed Infant Formula and Early β-Cell Autoimmunity A Randomized Clinical Trial
Mikael Knip et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Monoclonal antibody blocking the recognition of an insulin peptide-MHC complex modulates type 1 diabetes
Li Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Teplizumab (Anti-CD3 mAb) Treatment Preserves C-Peptide Responses in Patients With New-Onset Type 1 Diabetes in a Randomized Controlled Trial Metabolic and Immunologic Features at Baseline Identify a Subgroup of Responders
Kevan C. Herold et al.
DIABETES (2013)
Teplizumab Preserves C-Peptide in Recent-Onset Type 1 Diabetes
William Hagopian et al.
DIABETES (2013)
Teplizumab treatment may improve C-peptide responses in participants with type 1 diabetes after the new-onset period: a randomised controlled trial
K. C. Herold et al.
DIABETOLOGIA (2013)
Seroconversion to Multiple Islet Autoantibodies and Risk of Progression to Diabetes in Children
Anette G. Ziegler et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials
Antoinette Moran et al.
LANCET (2013)
Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial
Stephen E. Gitelman et al.
LANCET DIABETES & ENDOCRINOLOGY (2013)
Removal of Bovine Insulin From Cow's Milk Formula and Early Initiation of Beta-Cell Autoimmunity in the FINDIA Pilot Study
Outi Vaarala et al.
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE (2012)
Prevention of Type 1 Diabetes in the Rat With an Allele-Specific Anti T-Cell Receptor Antibody Vβ13 as a Therapeutic Target and Biomarker
Zhijun Liu et al.
DIABETES (2012)
Fall in C-Peptide During First 2 Years From Diagnosis Evidence of at Least Two Distinct Phases From Composite Type 1 Diabetes Trial Net Data
Carla J. Greenbaum et al.
DIABETES (2012)
Early seroconversion and rapidly increasing autoantibody concentrations predict prepubertal manifestation of type 1 diabetes in children at genetic risk
V. Parikka et al.
DIABETOLOGIA (2012)
GAD65 Antigen Therapy in Recently Diagnosed Type 1 Diabetes Mellitus
Johnny Ludvigsson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Markedly reduced rate of diabetic ketoacidosis at onset of type 1 diabetes in relatives screened for islet autoantibodies
Christiane Winkler et al.
PEDIATRIC DIABETES (2012)
Genetics of Type 1 Diabetes
Janelle A. Noble et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Independence of exogenous insulin following immunoablation and stem cell reconstitution in newly diagnosed diabetes type I
E. Snarski et al.
BONE MARROW TRANSPLANTATION (2011)
Age of Islet Autoantibody Appearance and Mean Levels of Insulin, but Not GAD or IA-2 Autoantibodies, Predict Age of Diagnosis of Type 1 Diabetes
Andrea K. Steck et al.
DIABETES CARE (2011)
Reduced Prevalence of Diabetic Ketoacidosis at Diagnosis of Type 1 Diabetes in Young Children Participating in Longitudinal Follow-Up
Helena Elding Larsson et al.
DIABETES CARE (2011)
Phase 1 (Safety) Study of Autologous Tolerogenic Dendritic Cells in Type 1 Diabetic Patients
Nick Giannoukakis et al.
DIABETES CARE (2011)
Prevention of type 1 diabetes in mice by tolerogenic vaccination with a strong agonist insulin mimetope
Carolin Daniel et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Structure-Based Selection of Small Molecules To Alter Allele-Specific MHC Class II Antigen Presentation
Aaron W. Michels et al.
JOURNAL OF IMMUNOLOGY (2011)
Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial
Diane K. Wherrett et al.
LANCET (2011)
Teplizumab for treatment of type 1 diabetes (Protege study): 1-year results from a randomised, placebo-controlled trial
Nicole Sherry et al.
LANCET (2011)
Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial
Tihamer Orban et al.
LANCET (2011)
Specificity and detection of insulin-reactive CD4+ T cells in type 1 diabetes in the nonobese diabetic (NOD) mouse
Frances Crawford et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Immune intervention in type 1 diabetes
Aaron W. Michels et al.
SEMINARS IN IMMUNOLOGY (2011)
2011 Update: antigen-specific therapy in type 1 diabetes
Aaron W. Michels et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2011)
Antigen-Specific Immunotherapy for Type 1 Diabetes: Maximizing the Potential
Mark Peakman et al.
DIABETES (2010)
Dietary Intervention in Infancy and Later Signs of Beta-Cell Autoimmunity.
Mikael Knip et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Diabetogenic T cells recognize insulin bound to IAg7 in an unexpected, weakly binding register
Brian D. Stadinski et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Proinsulin peptide immunotherapy in type 1 diabetes: report of a first-in-man Phase I safety study
S. L. Thrower et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
Treatment of patients with new onset Type 1 diabetes with a single course of anti-CD3 mAb teplizumab preserves insulin production for up to 5 years
Kevan C. Herold et al.
CLINICAL IMMUNOLOGY (2009)
Insulin treatment in IA-2A-positive relatives of type 1 diabetic patients
E. Vandemeulebroucke et al.
DIABETES & METABOLISM (2009)
C-Peptide Levels and Insulin Independence Following Autologous Nonmyeloablative Hematopoietic Stem Cell Transplantation in Newly Diagnosed Type 1 Diabetes Mellitus
Carlos E. B. Couri et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Genetics of Type 1A Diabetes
Patrick Concannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function
Mark D. Pescovitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial results
Jeffrey L. Mahon et al.
PEDIATRIC DIABETES (2009)
Type 1 Diabetes TrialNet-An International Collaborative Clinical Trials Network
Jay S. Skyler et al.
Immunology of Diabetes V: From Bench to Bedside (2008)
HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: Analysis of the Type 1 Diabetes Genetics Consortium families
Henry Erlich et al.
DIABETES (2008)
Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial
Kirsti Nanto-Salonen et al.
LANCET (2008)
Concordance for Islet Autoimmunity among Monozygotic Twins
Maria J. Redondo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
GAD treatment and insulin secretion in recent-onset type 1 diabetes
Johnny Ludvigsson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Omega-3 polyunsaturated fatty acid intake and islet autoimmunity in children at increased risk for type 1 diabetes
Jill M. Norris et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Treatment of new-onset type 1 diabetes with peptide DiaPep277® is safe and associated with preserved beta-cell function:: extension of a randomized, double-blind, phase II trial
I. Raz et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2007)
Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus
Julio C. Voltarelli et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Depressive symptoms in children and adolescents with type 1 diabetes - Association with diabetes-specific characteristics
Korey K. Hood et al.
DIABETES CARE (2006)
Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice
M Nakayama et al.
NATURE (2005)
Neonatal Bacille Camette-Guerin vaccination and type 1 diabetes
M Huppmann et al.
DIABETES CARE (2005)
European Nicotinamide Diabetes Intervention Trial (ENDIT):: a randomised controlled trial of intervention before the onset of type 1 diabetes
EAM Gale et al.
LANCET (2004)
Pancreatic β-cell function and immune responses to insulin after administration of intranasal insulin to humans at risk for type 1 diabetes
LC Harrison et al.
DIABETES CARE (2004)
Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY)
JM Barker et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus
KC Herold et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
β-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277):: a randomised, double-blind, phase II trial
I Raz et al.
LANCET (2001)
A disease-associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulin
DG Alleva et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Share Paper
